This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

New Controversies and Concerns Associated with Orange Book Listings and Labeling Strategies

October 7, 2010, American Conference Institute, 11th Annual Conference on Maximizing Pharmaceutical Patent Life Cycles, New York City

Share this article: